Skip to main content
Terug
Watch Compare

Burning Rock Biotech Ltd

Datakwaliteit: 100%
BNR
NASDAQ Services Health Services
€ 17,89
▼ € 0,04 (-0,22%)
Marktkapitalisatie: 176,79 M
6 months return
—
Momentum
Neutral
5Y revenue growth
1,77%

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue grew 1,77% annually over 5 years — modest growth
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -13,38 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 8,41%
Capital efficient — spends only 1,05% of revenue on capex

Price History

Groei

Revenue Growth (5Y)
1,77%
Onder sectorgemiddelde (3,99%)
Revenue (1Y)-6,64%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-50,57%
Onder sectorgemiddelde (-15,99%)
ROIC-39,86%
Net Margin-67,20%
Op. Margin-69,32%

Veiligheid

Debt / Equity
0,00
Onder sectorgemiddelde (0,39)
Current Ratio4,07
Interest CoverageN/A

Waardering

PE (TTM)
-3,72
Onder sectorgemiddelde (-1,18)
P/B Ratio0,83
EV/EBITDAN/A
Dividend YieldN/A

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (615 peers)
Metriek Aandeel Sector Mediaan
P/E -3,7 -1,2
P/B 0,8 1,4
ROE % -50,6 -16,0
Net Margin % -67,2 -18,7
Rev Growth 5Y % 1,8 4,0
D/E 0,0 0,4

Koersdoel Analisten

Consensus van analisten: gemiddeld koersdoel vs huidige prijs en beoordeling.

Geen analistendekking beschikbaar

Winstschattingen

Analistprognoses voor EPS en omzet per periode. Jaar = boekjaren; kwartaal = komende kwartalen.

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q12023 -€ 13,90 -€ 18,10 -30,2%
Q42022 -€ 19,00 -€ 21,10 -11,1%
Q32022 -€ 18,80 -€ 23,30 -23,9%
Q22022 -€ 18,50 -€ 25,00 -35,1%

ETFs Holding This Stock

BAHAX BAHAX
2,40% weight
BAFHX BAFHX
2,40% weight
YAFIX YAFIX
1,26% weight
YAFFX YAFFX
1,26% weight
TBGVX TBGVX
0,88% weight
TWEBX TWEBX
0,84% weight
YFSIX YFSIX
0,66% weight
YFSNX YFSNX
0,66% weight
FGM logo FGM First Trust Germany AlphaDEX Fund
0,65% weight
RFEU RFEU
0,53% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -6,64% Revenue Growth (3Y) -6,98%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 1,77% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 70,67 M Net Income (TTM) -47,49 M
ROE -50,57% ROA -35,47%
Gross Margin 70,25% Operating Margin -69,32%
Net Margin -67,20% Free Cash Flow (TTM) -13,38 M
ROIC -39,86% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 4,07
Interest Coverage N/A Asset Turnover 0,53
Working Capital 164,77 M Tangible Book Value 213,33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3,72 Forward P/E N/A
P/B Ratio 0,83 P/S Ratio 2,50
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7,57%
Market Cap 176,79 M Enterprise Value 5,66 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 6,56
FCF / Share -1,24 OCF / Share -1,17
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,05% FCF Conversion 28,18%
SBC-Adj. FCF -34,70 M Growth Momentum -8,41

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 70,67 M 75,70 M 81,66 M 79,69 M 65,89 M
Net Income -47,49 M -92,07 M -140,82 M -125,02 M -62,41 M
EPS (Diluted) — — — — —
Gross Profit 49,65 M 51,16 M 55,10 M 57,14 M 48,11 M
Operating Income -48,99 M -94,27 M -142,15 M -125,08 M -63,21 M
EBITDA — — — — —
R&D Expenses 31,82 M 48,88 M 61,17 M 57,73 M 40,45 M
SG&A Expenses — — — — —
D&A 7,15 M 18,79 M 17,99 M 7,50 M 5,11 M
Interest Expense 0,0 0,0 15.000,0 241.000,0 102.000,0
Income Tax 806.000,0 336.000,0 288.000,0 141.000,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 121,29 M 146,48 M 230,16 M 357,56 M 408,13 M
Total Liabilities 41,71 M 38,25 M 62,22 M 67,99 M 37,09 M
Shareholders' Equity 79,57 M 108,23 M 167,94 M 289,57 M 371,04 M
Total Debt — — 0,0 372.000,0 1,13 M
Cash & Equivalents 71,22 M 86,63 M 131,28 M 224,61 M 290,47 M
Current Assets 106,40 M 124,52 M 182,50 M 285,75 M 386,77 M
Current Liabilities 36,48 M 37,10 M 59,66 M 58,41 M 37,02 M